The coronavirus morbidity rate in Ukraine has increased for the first time in several months. Viktor Lyashko, the Healthcare Minister of Ukraine said so as cited by press service of the Office of the President.
The number of newly infected people grew over the last week.
"Specifically, 3,460 newly infected were observed over the last week; that's 253 more than during the previous period", reads the message.
Earlier, we reported that the vaccines used for inoculations of the locals in India, including Russia's Sputnik V are considered effective for combating the Delta strain. Dr. N.K. Arora, the Chair of Indian SARS-CoV-2 Genomics Consortium said so in his commentary for Indian news agency ANI.
The official cited the ICMR, the Indian Council of Medical Research, which conducted the respective study that proved the efficiency of these vaccines against this particular strain.
Currently, India uses the vaccine of Indian Institute of Serum (CoviShield), which was created under the license from AstraZeneca, Russia's Sputnik V and a drug developed by Bharat Biotech Covaxin.